Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,829 | 742 | 89.3% |
| Travel and Lodging | $1,160 | 3 | 10.5% |
| Education | $23.33 | 10 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $1,605 | 98 | $0 (2022) |
| Medtronic USA, Inc. | $1,573 | 14 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $839.94 | 45 | $0 (2021) |
| Collegium Pharmaceutical, Inc. | $746.72 | 106 | $0 (2021) |
| PFIZER INC. | $690.09 | 103 | $0 (2020) |
| Supernus Pharmaceuticals, Inc. | $597.37 | 53 | $0 (2021) |
| Amgen Inc. | $543.36 | 23 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $543.27 | 46 | $0 (2021) |
| Depomed, Inc. | $409.17 | 38 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $296.79 | 19 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $18.98 | 1 | Daiichi Sankyo Inc. ($18.98) |
| 2021 | $1,295 | 70 | Biohaven Pharmaceuticals, Inc. ($256.57) |
| 2020 | $1,109 | 63 | Amgen Inc. ($279.70) |
| 2019 | $3,404 | 176 | Medtronic USA, Inc. ($1,547) |
| 2018 | $2,076 | 200 | Takeda Pharmaceuticals U.S.A., Inc. ($285.94) |
| 2017 | $3,109 | 245 | Daiichi Sankyo Inc. ($1,176) |
All Payment Transactions
755 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/31/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/12/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Gastroenterology | ||||||
| 09/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Neuroscience | ||||||
| 09/08/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Gastroenterology | ||||||
| 08/25/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Neuroscience | ||||||
| 08/13/2021 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $12.50 | General |
| Category: AED | ||||||
| 08/12/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: NEUROSCIENCE | ||||||
| 08/10/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.12 | General |
| Category: Opioid Analgesic | ||||||
| 08/04/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Gastroenterology | ||||||
| 08/03/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Chronic Pain | ||||||
| 07/28/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Gastroenterology | ||||||
| 07/28/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $8.89 | General |
| Category: Opioid Analgesic | ||||||
| 07/27/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Neuroscience | ||||||
| 07/20/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Neuroscience | ||||||
| 07/13/2021 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $12.55 | General |
| Category: AED | ||||||
| 07/08/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $6.34 | General |
| Category: Opioid Analgesic | ||||||
| 06/28/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Neuroscience | ||||||
| 06/25/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.38 | General |
| Category: Opioid Analgesic | ||||||
| 06/24/2021 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Analgesic | ||||||
| 06/22/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Chronic Pain | ||||||
| 06/21/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 986 | 1,132 | $137,298 | $70,946 |
| 2020 | 3 | 1,193 | 2,107 | $240,605 | $74,441 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 392 | 496 | $54,560 | $32,890 | 60.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 256 | 295 | $43,328 | $27,454 | 63.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 308 | 311 | $34,160 | $9,160 | 26.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 30 | 30 | $5,250 | $1,442 | 27.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 1,002 | 1,898 | $208,780 | $65,189 | 31.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 141 | 159 | $27,825 | $8,290 | 29.8% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Facility | 2020 | 50 | 50 | $4,000 | $962.80 | 24.1% |
About Dr. Melanie Ledford, MD
Dr. Melanie Ledford, MD is a Physical Medicine & Rehabilitation healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710085196.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melanie Ledford, MD has received a total of $11,012 in payments from pharmaceutical and medical device companies, with $18.98 received in 2022. These payments were reported across 755 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($9,829).
As a Medicare-enrolled provider, Ledford has provided services to 2,179 Medicare beneficiaries, totaling 3,239 services with total Medicare billing of $145,387. Data is available for 2 years (2020–2021), covering 7 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Lexington, KY
- Active Since 09/20/2006
- Last Updated 08/19/2019
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1710085196
Products in Payments
- SYNCHROMED (Device) $1,552
- Morphabond ER (Drug) $1,156
- TROKENDI XR (Drug) $597.37
- LYRICA (Drug) $552.53
- Movantik (Drug) $525.82
- XTAMPZA (Drug) $490.67
- Amitiza (Drug) $475.66
- RELISTOR (Drug) $447.09
- Aimovig (Biological) $399.12
- Nucynta (Drug) $396.87
- RELISTOR ORAL (Drug) $298.20
- MOVANTIK (Drug) $296.79
- NURTEC ODT (Drug) $256.57
- LUCEMYRA (Drug) $223.28
- Lucemyra/Lofexidine (Drug) $206.03
- Horizant (Drug) $191.04
- AIMOVIG (Biological) $189.57
- Xtampza ER (Drug) $166.37
- UBRELVY (Drug) $159.54
- Senza Spinal Cord Stimulation System (Device) $157.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Lexington
Clay Guynn, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $117,679
Brock Marrs, Md, MD
Physical Medicine & Rehabilitation — Payments: $8,534
Raechel Percy, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $7,653
Dr. Steven Ganzel, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $3,393
Cecil Hollen, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $3,103
Sara Shahid Salles, Do, DO
Physical Medicine & Rehabilitation — Payments: $2,740